Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sommadossi

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|October 2, 2019
Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosisElina Berliba, Maxim Bogus, Frédéric Vanhoutte, et al.
Nucleic Acids Research|December 14, 2023
An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complexAshleigh Shannon, Aurélie Chazot, Mikael Feracci, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeysL T Martin, E Cretton-Scott, R F Schinazi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2026
Consecutive catalytic steps of viral RNA polymerase and exonuclease suggest a way to overcome intrinsic nucleotide analogue resistanceAshleigh Shannon, Véronique Fattorini, Candice Sartre, et al.
Nucleosides & Nucleotides|August 5, 1999
Intracellular metabolism of beta-L-ddAMP-bis(tbutylSATE), a potent inhibitor of hepatitis B virus replicationA Faraj, L Placidi, C Perigaud, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineR F Schinazi, A McMillan, D Cannon, et al.
Antiviral Research|April 20, 2000
Synthesis and antiviral evaluation of some beta-L-2', 3'-dideoxy-5-chloropyrimidine nucleosides and pronucleotidesC Pierra, J L Imbach, E De Clercq, et al.
Journal of Medicinal Chemistry|November 8, 1996
In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddIT Koudriakova, K K Manouilov, K Shanmuganathan, et al.
JAMA|January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimensD V Havlir, N S Hellmann, C J Petropoulos, et al.
The Journal of Infectious Diseases|July 7, 2000
In vivo antagonism with zidovudine plus stavudine combination therapyD V Havlir, C Tierney, G H Friedland, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|October 2, 2019
Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosisElina Berliba, Maxim Bogus, Frédéric Vanhoutte, et al.
Nucleic Acids Research|December 14, 2023
An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complexAshleigh Shannon, Aurélie Chazot, Mikael Feracci, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeysL T Martin, E Cretton-Scott, R F Schinazi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2026
Consecutive catalytic steps of viral RNA polymerase and exonuclease suggest a way to overcome intrinsic nucleotide analogue resistanceAshleigh Shannon, Véronique Fattorini, Candice Sartre, et al.
Nucleosides & Nucleotides|August 5, 1999
Intracellular metabolism of beta-L-ddAMP-bis(tbutylSATE), a potent inhibitor of hepatitis B virus replicationA Faraj, L Placidi, C Perigaud, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineR F Schinazi, A McMillan, D Cannon, et al.
Antiviral Research|April 20, 2000
Synthesis and antiviral evaluation of some beta-L-2', 3'-dideoxy-5-chloropyrimidine nucleosides and pronucleotidesC Pierra, J L Imbach, E De Clercq, et al.
Journal of Medicinal Chemistry|November 8, 1996
In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddIT Koudriakova, K K Manouilov, K Shanmuganathan, et al.
JAMA|January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimensD V Havlir, N S Hellmann, C J Petropoulos, et al.
The Journal of Infectious Diseases|July 7, 2000
In vivo antagonism with zidovudine plus stavudine combination therapyD V Havlir, C Tierney, G H Friedland, et al.
Pageof 18